SAN FRANCISCO (GenomeWeb) – A research team from the National University of Singapore has developed a targeted sequencing method to calculate fetal fraction in cell-free DNA from maternal plasma, which it plans to use in research studies to develop noninvasive prenatal screens for single-gene disorders like beta thalassemia.
Singapore Team Develops Sequencing Method to Calculate Fetal Fraction for Targeted Prenatal Tests
Premium
Get the full story with
360Dx Premium
Only $95 for the
first 90 days*
360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a 360Dx or GenomeWeb Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.